upsid price
return equiti ltm
note pleas refer page end
report import disclosur
bottom line varian report adjust ep figur quarter
versu expect consensu estim
stronger-than-expect revenu better-than-model gross margin result
primari reason posit adjust ep surpris
guidanc rais upgrad rate price target
top line varian report revenu million versu estim
million consensu estim million look revenu
oper segment oncolog system revenu came except strong
million versu estim million particl therapi
segment actual fell bit short expect come million
versu estim million
balanc sheet cash flow varian end quarter cash
equival approxim million total debt million
flow oper quarter roughli million strong
result put cash flow perform perspect cash flow
oper full-year approxim million
outlook varian increas top-lin growth guidanc
previous adjust ep expect rang
previou rang flow oper expect
track million million
recommend upgrad share outperform
invest rate light strong first quarter result well solid
like conserv outlook remaind year price target
arriv price target attach multipl adjust
ebitda estim assum million net cash month
revenu mil estimate bold
ep estimate bold
overal varian medic deliv strong fiscal first quarter overal revenu
adjust ep easili beat expect well consensu
compani also increas fiscal guidanc meaning manner term
top line well profit
revenu look revenu oper segment oncolog system revenu came
million well estim million compani
overal revenu segment report basi term
constant currenc strong linac system sale credit play
signific role outstand result
varian particl therapi segment deliv million versu million
estim written previous busi lumpi pretti tough
model quarterli basi therefor slight revenu shortfal rel model
particular concern
gross margin oper expens total consolid gross margin came
versu estim good result driven oncolog
show bp declin yoy term gross margin
report sg expens quarter came revenu versu
model
 expens revenu line model line item
profit adjust ep versu estim consensu
estim
balanc sheet cash flow varian end quarter cash equival
approxim million total debt million flow
oper strong quarter total roughli million
varian report strong first quarter result compani revenu growth
approxim outstand order momentum also solid
addit compani also disclos demonstr order growth
region quarter final manag increas financi guidanc
term revenu adjust ep highlight strength
see oncolog space gener well belief varian
success captur market share short highli encourag earn
varian financi guidanc includ expect organ
revenu growth guidanc evid includ much anyth term
foreign currenc tailwind think like base recent trend addit
full-year guidanc includ first quarter top-lin growth given
backdrop strongli suspect potenti upsid least lower end
guidanc rang current model full-year revenu growth
compani overal revenu increas report basi
constant currenc quarter compani credit quick convers
order revenu matur market among key driver strong top-lin
result addit manag team believ growth profil overal
oncolog space meaning improv recent month
overal compani revenu america increas whop dollar
constant currenc quarter revenu europ middl east india
africa region dollar constant currenc final asia-
pacif region show growth dollar growth constant currenc
oncolog revenu growth dollar constant currenc
result larg fuel growth america region growth
asia-pacif region dollar emeia region also demonstr solid growth
rate dollar
product revenu within oncolog report term
constant currenc servic revenu show growth report growth
constant currenc
gross oncolog order quarter dollar constant
currenc america gross order increas dollar constant
currenc win includ halcyon order brazil aruba dominican republ
two truebeam sale ucsf mission bay varieti product sold
europ middl east africa india region gross oncolog order increas
strong dollar constant currenc signific order spain
denmark india poland among key good result final gross
oncolog order asia-pacif region increas quarter strength
china among highlight
varian gross margin within oncolog busi increas bp
quarter varian oper margin oncolog demonstr even bigger
improv come increas bp certainli expect see
continu margin expans within busi next coupl year
though compani record new order halcyon quarter
think manag would conced compani yet realli hit stride
term order rel new product unveil astro
show vienna may said clear varian continu optimist
term futur halcyon share view suspect breakthrough
quarter halcyon order like come point fiscal year
addit compani express hope belief regulatori
approv china halcyon could come point next six nine month
varian particl therapi busi gener million revenu
quarter book two gross order total million order
 busi continu expand footprint given credit
margin profil continu leav much desir
varian full-year financi guidanc includ adjust ep
approxim revenu growth adjust oper margin expect
revenu cash flow oper project
million million guidanc given term expect
capit expenditur free cash flow year
varian continu activ share repurchas activ repurchas
approxim million share quarter roughli million share
compani still approxim million share remain current share
repurchas author model meaning share repurchas
activ remaind fiscal year
upgrad varian share outperform invest rate given
compani outstand first quarter result well solid like conserv
financi guidanc remaind year price target arriv
price target attach multipl adjust ebitda estim
assum million net cash month
revenu
interest incom net
 revenu
sg revenu
pre-shar repo chg wc
million except per share data
expect outperform th mark et ov er nex onth
sound im prove com pa ny fundament
potenti exi ts near -term catali
underv alu current lev el
expect perform roug hl line ith arket next month
long-term potenti exi st near-term atali st appar
fairli valu current lev el
expect under-perform arket next onth
com pani fundament ay deterior
fulli valu ov er-valu urrent level
devel ope pric target com pan use ev/ebitd howev er
risk target pric ill ac hiev ed he clude limit failur
 ompani eet revenu earn estim
follow list rate co mpani over barrington esearch soc iat
inc ecem ber num ber ompani rate ut perf rm
repr ent om pani cov erag list number com pani rate
ket perfo repr ent com pani coverag list
num ompani rate un der perf rm repres
com pani overag list al dec ember barrington esearch
ass ociat inc provid inv estment bank ing erv ic es within la onth
com pani ut perf rm rate om pani
arket per fo rate ompani
alyst ertificatio re earch anali respon ibl prepar re earch report ha el petusk cfa herebi ertifi
 iew om pani sec uriti expr sed report acc urat reflec person opinion anal yst also
certifi part com pe ns ation directli indirectli relat pecif rec omm endat iew ontain report
earch anali ts inc ludi ng inv olv ed prepar report receiv ed direc ompens onnect firm
inv tm ent bank activ es anali om pensat whic ade alari bonu ba ed upo num erou factor includ
stock pric performanc ualiti anali inv tor client feedbac ell ov eral profit firm impac ted
firm bu iness activ inc lude ong thing institut equiti trade inv estment bank ing serv ice
inv estment bank ing erv ic es defin asd rule includ among thing ac ting un der writer member
ell group ecur es und rwrite al yst re ponsibl thi report ichael petusk cfa mem ber anali st
household hare omm toc compani asd regul adopt rule prohibit researc anal yst
trade ecur cov er ed com pani spec ifi tim period public ation re earch report
barrington earch ass ociat inc full- ervic financi erv ice firm offer ide arieti servic es produc ts lient
inv estor ho uld sum barrington esearc seek ing ill seek inv estment bank ing busin relat hip
com pani researc cov erag barrington esearch rec eiv inv es tm ent bank ing-rel com pensat
com pani within past month expect ithin next three month
barrington research associ inc finra-regist broker/deal clear nation financi nf
fulli disclos basi conveni client offer sever way client facilit payment
trade barrington research order may place trade desk
trader michael hutchison head trader christoph cottrel email address
instant messeng address brrrmh
trade broker trade may also stepped-in barrington research trade execut broker
commiss share arrang barrington commiss share agreement numer broker wall
street complet list commiss share program barrington research particip pleas contact
salesperson trade desk
follow list provid barrington research trade alloc settlement id nf dtc code execut
question trade set account relat inform pleas call trade depart
inform contain herein obtain sourc believ reliabl guarante accuraci complet
opinion estim reflect best judgment report date subject chang without notic report intend inform
purpos constitut offer solicit buy sell secur barrington research associ inc affili offic
analyst employe may time time posit secur refer herein barrington research associ inc may act
princip agent buyer seller purchas sale secur mention report barrington research associ
inc may provid may seek provid invest bank servic compani mention report report may
reproduc form without prior written consent barrington research associ inc right reserv member finra/sipc
